Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease.
Jones, Roy W
Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease. [electronic resource] - International journal of geriatric psychiatry Mar 2007 - 258-62 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0885-6230
10.1002/gps.1752 doi
Aged
Aged, 80 and over
Alzheimer Disease--drug therapy
Anxiety--chemically induced
Dopamine Agents--administration & dosage
Double-Blind Method
Drug Administration Schedule
Female
Humans
Least-Squares Analysis
Male
Memantine--administration & dosage
Mental Disorders--chemically induced
Neuropsychological Tests
Patient Selection
Safety
Treatment Outcome
Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease. [electronic resource] - International journal of geriatric psychiatry Mar 2007 - 258-62 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0885-6230
10.1002/gps.1752 doi
Aged
Aged, 80 and over
Alzheimer Disease--drug therapy
Anxiety--chemically induced
Dopamine Agents--administration & dosage
Double-Blind Method
Drug Administration Schedule
Female
Humans
Least-Squares Analysis
Male
Memantine--administration & dosage
Mental Disorders--chemically induced
Neuropsychological Tests
Patient Selection
Safety
Treatment Outcome